MARK DIRNBERGER: Open Payments
NPI 1841366465 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 29 payments from 13 companies in 2025. Trend: 2023 $1,009 · 2024 $939 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 5 | $149 |
| Azurity Pharmaceuticals, Inc. | 5 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $72 |
| BIOTRONIK NRO, Inc. | 2 | $55 |
| SI-BONE, INC. | 2 | $45 |
| Valinor Pharma, LLC | 2 | $26 |
| ABBVIE INC. | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: QUTENZA, HORIZANT, JOURNAVX, RELISTOR, MOVANTIK, Prospera, UBRELVY, TONMYA.
Industry payments across TX — which companies pay providers there.
